Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ HF Sinclair targets 10% annual branded site growth and launches Green Trail Fuels JV while addressing... (SeekingAlpha) +++ HF SINCLAIR Aktie +4,78%

KENVUE Aktie

 >KENVUE Aktienkurs 
15.884 EUR    +2.2%    (TradegateBSX)
Ask: 16.102 EUR / 1870 Stück
Bid: 15.934 EUR / 1890 Stück
Tagesumsatz: 986 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
KENVUE Aktie über LYNX handeln
>KENVUE Performance
1 Woche: +1,2%
1 Monat: +5,5%
3 Monate: +10,8%
6 Monate: -14,5%
1 Jahr: -26,5%
laufendes Jahr: +6,1%
>KENVUE Aktie
Name:  KENVUE INC. DL -,001
Land:  USA
Sektor:  Konsumgueter / Gastronomie
ISIN/ Wkn:  US49177J1025 / A3EEHU
Symbol/ Ticker:  J4D (Frankfurt) / KVUE (NYSE)
Kürzel:  FRA:J4D, ETR:J4D, J4D:GR, NYSE:KVUE
Index:  -
Webseite:  https://www.kenvue.com/
Profil:  Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-ro..
>Volltext..
Marktkapitalisierung:  30281.92 Mio. EUR
Unternehmenswert:  37083.99 Mio. EUR
Umsatz:  12681.76 Mio. EUR
EBITDA:  2787.37 Mio. EUR
Nettogewinn:  1211.13 Mio. EUR
Gewinn je Aktie:  0.63 EUR
Schulden:  7698.65 Mio. EUR
Liquide Mittel:  962.65 Mio. EUR
Operativer Cashflow:  1805.28 Mio. EUR
Bargeldquote:  0.19
Umsatzwachstum:  -7.9%
Gewinnwachstum:  27.79%
Dividende je Aktie:  0.71 EUR
Dividendenrendite:  4.41%
Dividendenschätzung:  4.44%
Div. Historie:  11.02.26 - 0.17432074€
12.11.25 - 0.17892724€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  KENVUE
Letzte Datenerhebung:  18.02.26
>KENVUE Kennzahlen
Aktien/ Unternehmen:
Aktien: 1916.01 Mio. St.
Frei handelbar: 99.94%
Rückkaufquote: 0.89%
Mitarbeiter: 22000
Umsatz/Mitarb.: 0.59 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 0.43%
Bewertung:
KGV: 24.73
KGV lG: 17.86
KUV: 2.36
KBV: 3.31
PEG-Ratio: 0.72
EV/EBITDA: 13.3
Rentabilität:
Bruttomarge: 58.21%
Gewinnmarge: 9.55%
Operative Marge: 18.2%
Managementeffizenz:
Gesamtkaprendite: 5.29%
Eigenkaprendite: 13.47%
>KENVUE Peer Group
Konsumgueter / Gastronomie
 
18.02.26 - 19:18
Kenvue Analysts Boost Their Forecasts After Upbeat Q4 Earnings (Benzinga)
 
Importance Rank:  1 read more...
18.02.26 - 19:00
Kenvue Tops Q4 Earnings Estimates, Advances Toward Kimberly-Clark Deal (Zacks)
 
KVUE reports solid Q4 results, with margin gains and broad-based global growth, while moving closer to its planned Kimberly-Clark acquisition....
18.02.26 - 14:12
Kenvue Surges as Earnings Beat, Kimberly-Clark Merger Gains Steam (24/7 Wall St.)
 
Kenvue (NYSE: KVUE) reported fourth-quarter results yesterday that exceeded analyst expectations, with adjusted EPS of $0.27 beating the FactSet estimate of $0.22 by 23%. Revenue of $3.78 billion topped the $3.68 billion consensus, marking a solid finish to a year otherwise defined by declining sales. This morning, the stock traded at $18.41, up 1.3% over ... Kenvue Surges as Earnings Beat, Kimberly-Clark Merger Gains Steam The post Kenvue Surges as Earnings Beat, Kimberly-Clark Merger Gains Steam appeared first on 24/7 Wall St.....
18.02.26 - 00:42
Starboard Value raises stakes in Kenvue, Riot Platforms (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
17.02.26 - 23:54
Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal (WSJ EN)
 
The job cuts are part of a restructuring plan to optimize its operating model and drive operational efficiencies, the company said....
17.02.26 - 23:48
Kenvue Inc. Profit Climbs In Q4 (AFX)
 
WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) announced earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line came in at $330 million, or $0.17 per sh......
17.02.26 - 23:12
Kenvue Non-GAAP EPS of $0.27 beats by $0.05, revenue of $3.78B beats by $90M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.02.26 - 22:48
Kenvue Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
 
Q4 Net Sales 3.2%; Organic Sales1 1.2% Q4 Diluted EPS was $0.17; Adjusted Diluted EPS1 was $0.27 FY'25 Net Sales (2.1)%; Organic Sales (2.2)% FY'25 Diluted EPS was $0.76; Adjusted Diluted EPS was $1.08 SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal fourth quarter and full year ended December 28, 2025. “We ended 2025 with stronger top- and bottom-line performance in the fourth quarter, which reflected both disciplined execution against our strategic priorities, as well as a more favorable year-ago comparison on sales,” said Kirk Perry, Chief Executive Officer. “As we look to 2026, we remain focused on continuing to enhance our performance, while progressing toward completion of our value-creating combination with Kimberly-Clark.” Fourth Quarter Summary Net sales increased 3.2% vs the prior year period, primarily reflecting Organic sales1 growth of 1.2% and a foreign currency benefit of 2.1%. Gross profit margin was flat year-over-year at 5...
13.02.26 - 23:39
Kenvue Q4 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.02.26 - 15:30
What′s Going On With Neutrogena Maker Kenvue Stock On Thursday? (Benzinga)
 
Kenvue investors approve its sale to Kimberly-Clark. Stock nears 52-week lows ahead of February earnings, with mixed technical signals and cautious analyst ratings. Importance Rank:  1 read more...
04.02.26 - 12:48
Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026 (Business Wire)
 
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company's website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com. Contacts Investor Relations:Sofya Tsinis Kenvue_IR@Kenvue.com Media Relations:Melissa Witt Me...
30.01.26 - 17:57
Jefferies downgrades Kenvue as deal approval leaves limited upside (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
30.01.26 - 14:00
Here Are Friday′s Top Wall Street Analyst Research Calls: Broadcom, Circle Internet, Kenvue, Medtronic, Sandisk, Southwest Airlines, Spotify, and More (24/7 Wall St.)
 
Pre-Market Stock Futures: Futures are trading lower as we prepare to close out the trading week. What a difference a day can make. After a blockbuster rally on Wednesday, the stock market reversed course and sold off on Thursday, and that could carry over into today. While the major indices ended off their midday lows, ... Here Are Friday's Top Wall Street Analyst Research Calls: Broadcom, Circle Internet, Kenvue, Medtronic, Sandisk, Southwest Airlines, Spotify, and More The post Here Are Friday's Top Wall Street Analyst Research Calls: Broadcom, Circle Internet, Kenvue, Medtronic, Sandisk, Southwest Airlines, Spotify, and More appeared first on 24/7 Wall St.....
29.01.26 - 15:30
Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark′s Acquisition of Kenvue (PR Newswire)
 
Key Milestone in Creating a Global Health and Wellness Leader Transaction Expected to Close in the Second Half of 2026 DALLAS and SUMMIT, N.J., Jan. 29, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) and Kenvue Inc. (NYSE: KVUE) today announced that Kimberly-Clark and......
28.01.26 - 23:36
Kenvue Is Headed for a Merger Vote on January 29. How Should You Play KVUE Stock Here? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
28.01.26 - 13:18
Kenvue declares $0.2075 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.01.26 - 12:51
Kenvue Declares Quarterly Cash Dividend (Business Wire)
 
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on February 25, 2026, to shareholders of record as of the close of business on February 11, 2026. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com. Contacts Investor Relations:Sofya Tsinis Kenvue_IR@Kenvue.com Media Relations:Melissa Witt Media@Kenvue.com...
27.01.26 - 12:42
Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote (WSJ EN)
 
Kimberly-Clark reported a higher profit in its latest quarter just days before shareholders vote on its plan to buy Kenvue, a deal designed to create a global health-and-wellness giant....
16.01.26 - 19:24
Kimberly-Clark acquisition of Kenvue gains ISS recommendation (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Von allen Gütern ist das beste, ein edles Weib zu haben. - Euripides
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!